{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:37:35Z","timestamp":1792679855914,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.bpobgyn.2011.11.008","type":"journal-article","created":{"date-parts":[[2012,1,30]],"date-time":"2012-01-30T04:52:41Z","timestamp":1327899161000},"page":"379-390","source":"Crossref","is-referenced-by-count":150,"title":["Chemotherapy and fertility"],"prefix":"10.1016","volume":"26","author":[{"given":"Zeev","family":"Blumenfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2011.11.008_bib1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/OGX.0b013e318186aaea","article-title":"Present and future fertility preservation strategies for female cancer patients","volume":"63","author":"Georgescu","year":"2008","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/(SICI)1096-911X(199907)33:1<29::AID-MPO6>3.0.CO;2-2","article-title":"Pregnancy outcome in long-term survivors of childhood cancer","volume":"33","author":"Blatt","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/GRF.0b013e3181f96b54","article-title":"Toxicity of chemotherapy and radiation on female reproduction","volume":"53","author":"Meirow","year":"2010","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1470-2045(05)70092-9","article-title":"Fertility preservation for young patients with cancer: who is at risk and what can be offered?","volume":"6","author":"Wallace","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra043475","article-title":"Potential options for preservation of fertility in women","volume":"353","author":"Lobo","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib7","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1634\/theoncologist.12-9-1044","article-title":"Debate: how to preserve fertility in young women exposed to chemotherapy? The role of GnRH-agonist in addition to cryopreservation of embryos, oocytes, or ovaries","volume":"12","author":"Blumenfeld","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/humupd\/dmn022","article-title":"GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy","volume":"14","author":"Blumenfeld","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.fertnstert.2007.02.010","article-title":"Gonadotropin releasing hormone agonist decreases chemotherapy induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma","volume":"89","author":"Blumenfeld","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MED.0b013e32831a46e9","article-title":"GnRH-agonists in fertility preservation","volume":"15","author":"Blumenfeld","year":"2008","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1634\/theoncologist.2009-0269","article-title":"Repeated spontaneous pregnancies and successful deliveries after repeated autologous stem cell transplantation and GnRH-agonist","volume":"15","author":"Blumenfeld","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/1464727022000198942","article-title":"Radiation damage to the uterus \u2013 review of the effects of treatment of childhood cancer","volume":"5","author":"Critchley","year":"2002","journal-title":"Hum Fertil (Camb)"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib13","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/0360-3016(95)00025-T","article-title":"Radiation-induced premature menopause: a misconception","volume":"32","author":"Madsen","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib14","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1093\/oxfordjournals.humrep.a137985","article-title":"Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin\u2019s disease","volume":"8","author":"Familiari","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib15","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/0002-9343(81)90205-9","article-title":"Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin\u2019s disease","volume":"71","author":"Schilsky","year":"1981","journal-title":"Am J Med"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib16","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/OGX.0b013e318224e97b","article-title":"The effects of chemotherapy and radiotherapy on fertility in premenopausal women","volume":"66","author":"Fleischer","year":"2011","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejogrb.2006.08.006","article-title":"The effect of cancer treatment of female fertility and strategies for preserving fertility","volume":"130","author":"Maltaris","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0303-7207(01)00712-2","article-title":"Preservation of fertility and ovarian function and minimalization of chemotherapy associated gonadotoxicity and premature ovarian failure: the role of inhibin-A and -B as markers","volume":"187","author":"Blumenfeld","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib19","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1093\/humrep\/dei018","article-title":"Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma","volume":"20","author":"Dann","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00404-011-1874-1","article-title":"Fertility preservation in women-a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin\u2019s lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT","volume":"284","author":"von Wolff","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0027-5107(90)90058-C","article-title":"Female-specific dominant lethal effects in mice","volume":"230","author":"Katoh","year":"1990","journal-title":"Mutat Res"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1479-828X.2004.00143.x","article-title":"Effect of chemotherapy on primordial follicular reserve of rat: an animal model of premature ovarian failure and infertility","volume":"44","author":"Yucebilgin","year":"2004","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/10428199909093726","article-title":"Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radiochemotherapy for hemato-oncological neoplasias and other cancers","volume":"33","author":"Meirow","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib24","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/humrep\/dem027","article-title":"Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury","volume":"22","author":"Meirow","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib25","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1002\/1097-0142(19850515)55:10<2364::AID-CNCR2820551011>3.0.CO;2-E","article-title":"Gonadal effects of cancer therapy in girls","volume":"55","author":"Nicosia","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/ncponc0697","article-title":"Do survivors of childhood cancer have increased incidence of premature menopause?","volume":"4","author":"Critchley","year":"2007","journal-title":"Nature Clin Pract Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib27","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jnci\/djj243","article-title":"Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"98","author":"Sklar","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib28","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1200\/JCO.2008.21.1839","article-title":"Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study","volume":"27","author":"Green","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib29","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.ejca.2007.06.011","article-title":"Pregnancy in women who had cancer in childhood","volume":"43","author":"Edgar","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0303-7207(00)00365-8","article-title":"Reproduction post-chemotherapy in young cancer patients","volume":"169","author":"Meirow","year":"2000","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1210\/edrv-17-2-121","article-title":"Regulation of ovarian follicular development in primates: facts and hypotheses","volume":"17","author":"Gougeon","year":"1996","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ando.2010.02.021","article-title":"Human ovarian follicular development: from activation of resting follicles to preovulatory maturation","volume":"71","author":"Gougeon","year":"2010","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jncimonographs\/lgi025","article-title":"Appraisal of chemotherapy effects on reproductive outcome according to animal studies and clinical data","volume":"34","author":"Meirow","year":"2005","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib34","doi-asserted-by":"crossref","first-page":"7555","DOI":"10.1200\/JCO.2005.08.138","article-title":"Secondary amenorrhea after Hodgkin\u2019s lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin\u2019s Lymphoma Study Group","volume":"23","author":"Behringer","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib35","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.3324\/haematol.2011.045856","article-title":"Management of fertility in patients treated for Hodgkin lymphoma","volume":"96","author":"Harel","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007941.pub2","article-title":"Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma","author":"Bauer","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib37","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/10428190500353877","article-title":"Fertility status among women treated for aggressive non-Hodgkin\u2019s lymphoma","volume":"47","author":"Elis","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib38","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJM197605202942102","article-title":"Effects of childhood leukaemia and chemotherapy on puberty and reproductive function in girls","volume":"294","author":"Siris","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib39","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/1097-0142(19891201)64:11<2335::AID-CNCR2820641124>3.0.CO;2-7","article-title":"Pregnancy outcome after treatment for acute lymphoblastic leukaemia during childhood or adolescence","volume":"64","author":"Green","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mpo.2950210505","article-title":"Ovarian function following the treatment of childhood acute lymphoblastic leukaemia","volume":"21","author":"Wallace","year":"1993","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib41","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/ijc.26045","article-title":"Pregnancy after adolescent and adult cancer: a population-based matched cohort study","volume":"129","author":"Stensheim","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib42","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1191\/096120300678828596","article-title":"Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy","volume":"9","author":"Blumenfeld","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib43","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/art.21263","article-title":"Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus","volume":"52","author":"Somers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.autrev.2005.10.001","article-title":"Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study","volume":"5","author":"Manger","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib45","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1093\/humrep\/dep289","article-title":"IVF outcome in patients with orthotopically transplanted ovarian tissue","volume":"24","author":"Dolmans","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib46","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1182\/blood-2010-01-265751","article-title":"Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukaemia is potentially unsafe","volume":"116","author":"Dolmans","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib47","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.fertnstert.2009.11.032","article-title":"Evidence of residual disease in cryopreserved ovarian cortex from female patients with leukaemia","volume":"94","author":"Rosendahl","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib48","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/humrep\/deq121","article-title":"Occasional involvement of the ovary in Ewing sarcoma","volume":"25","author":"Abir","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib49","doi-asserted-by":"crossref","first-page":"803.e3","DOI":"10.1016\/j.fertnstert.2010.07.1068","article-title":"Detection of Hodgkin lymphoma within ovarian tissue","volume":"95","author":"Bittinger","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib50","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/j.fertnstert.2009.08.031","article-title":"Potential indications for ovarian autotransplantation based on the analysis of 5571 autopsy findings of females under the age of 40 in Japan","volume":"93","author":"Kyono","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib51","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ctrv.2010.07.007","article-title":"Luteinising hormone releasing hormone agonists (LH-RHa) in premenopausal early breast cancer patients: current role and future perspectives","volume":"37","author":"Del-Mastro","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib52","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1517\/14656566.2011.522568","article-title":"Medical approaches to preservation of fertility in female cancer patients [review]","volume":"12","author":"Del Mastro","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib53","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/jwh.2008.0857","article-title":"Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis","volume":"18","author":"Clowse","year":"2009","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib54","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10549-010-0996-7","article-title":"Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis","volume":"122","author":"Ben-Aharon","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib55","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/GRF.0b013e3181f96cb1","article-title":"Use of hormonal protection for chemotherapy-induced gonadotoxicity","volume":"53","author":"Kim","year":"2010","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib56","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.fertnstert.2010.11.017","article-title":"Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis","volume":"95","author":"Bedaiwy","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib57","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1095\/biolreprod52.2.365","article-title":"Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys","volume":"52","author":"Ataya","year":"1995","journal-title":"Biol Reprod"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib58","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.fertnstert.2007.12.044","article-title":"Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study","volume":"91","author":"Badawy","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib59","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10549-009-0313-5","article-title":"Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial","volume":"117","author":"Sverrisdottir","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib60","series-title":"American Society of Clinical Oncology 2008 educational book","first-page":"39","article-title":"Ovarian failure after chemotherapy for breast cancer and the role of gonadotropin-releasing hormone analogs in protection of ovarian function","author":"Moore","year":"2008"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib61","first-page":"269","article-title":"Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial","volume":"306","author":"Del Mastro","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib62","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00254570","article-title":"Failure to preserve fertility in patients with Hodgkin\u2019s disease","volume":"19","author":"Waxman","year":"1987","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib63","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1093\/annonc\/mdq066","volume":"21","author":"Behringer","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib64","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10815-008-9276-4","article-title":"Assessment of ovarian reserve following ovarian tissue banking and\/or GnRH-a co-treatment prior to chemotherapy in patients with Hodgkin\u2019s disease","volume":"25","author":"Azem","year":"2008","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib65","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00404-009-1308-5","article-title":"GnRH analogs do not protect ovaries from chemotherapy-induced ultrastructural injury in Hodgkin\u2019s lymphoma patients","volume":"282","author":"Nitzschke","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib66","unstructured":"Ismail-Khan R, Minton S, Cox C, et\u00a0al. 2008 Preservation of ovarian function in young women treated with neoadjuvant chemotherapy for breast cancer: a randomized trial using GnRH agonist (Triptorelin) during chemotherapy [abstract 524]. American Society of Clinical Oncology, annual meeting, 2008."},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib67","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1200\/JCO.2010.32.5704","article-title":"Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO Study","volume":"29","author":"Gerber","year":"2011","journal-title":"J Clin Oncol"},{"issue":"Suppl.","key":"10.1016\/j.bpobgyn.2011.11.008_bib68","first-page":"15s","article-title":"The OPTION trial of adjuvant ovarian protection by goserelin in adjuvant chemotherapy for early breast cancer","volume":"28","author":"Leonard","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib69","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1200\/JCO.2011.36.9850","article-title":"ZORO Study: discrepancy between the conclusion and the results","volume":"29","author":"Blumenfeld","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib70","doi-asserted-by":"crossref","DOI":"10.1007\/s10545-009-1095-y","article-title":"Four successful pregnancies in a patient with mucopolysaccharidosis type I treated by allogeneic bone marrow transplantation","author":"Rem\u00e9rand","year":"2009","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib71","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(01)05482-4","article-title":"Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey","volume":"358","author":"Salooja","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib72","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/sj.bmt.1705364","article-title":"Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study","volume":"37","author":"Carter","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib73","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0140-6736(07)60778-8","article-title":"Use of luteinizing-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials","volume":"369","author":"Cuzick","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib74","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/cncr.21646","article-title":"Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma","volume":"106","author":"Recchia","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib75","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJM200006223422506","article-title":"A comparison of observational studies and randomized, controlled trials","volume":"342","author":"Benson","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib76","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJM200006223422507","article-title":"Randomized, controlled trials, observational studies, and the hierarchy of research designs","volume":"342","author":"Concato","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpobgyn.2011.11.008_bib77","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/cncr.22199","article-title":"Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone\u2013releasing hormone agonist and depo-medroxyprogesterone acetate","volume":"107","author":"Meirow","year":"2006","journal-title":"Cancer"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693412000144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693412000144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T15:21:39Z","timestamp":1543245699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693412000144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1521693412000144"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2011.11.008","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}